Eli Lilly lowers full-year earnings outlook
April 24, 2014 at 08:35 AM EDT
Eli Lilly feels more strain from patent expirations for some of its bigger-selling drugs as first-quarter profit falls 53%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.